Literature DB >> 12960676

Vascular influences of calcium supplementation and vitamin D-induced hypercalcemia in NaCl-hypertensive rats.

Mika Kähönen1, Satu Näppi, Pasi Jolma, Nina Hutri-Kähönen, Jari-Petteri Tolvanen, Heikki Saha, Pasi Koivisto, Leena Krogerus, Jarkko Kalliovalkama, Ilkka Pörsti.   

Abstract

This 8-week study investigated the effects of increasing dietary Ca2+ content from 1.0% to 3.0% and hypercalcemia induced by oral 1alpha-OH vitamin D3 (1OH-D3, 1.2 microg/kg), on arterial tone in NaCl-hypertensive rats. The high-Ca2+ diet completely prevented the increase in blood pressure induced by the 6.0% NaCl chow, while plasma total Ca2+ and body weight were not different from controls. The 1OH-D3 treatment moderately elevated plasma total Ca2+ and attenuated the NaCl-induced rise in blood pressure, but also impaired weight gain. The tone of isolated mesenteric arterial rings was examined at the end of study. The endothelium-independent relaxations to nitroprusside, isoproterenol, and cromakalim were impaired in NaCl-hypertension. Experiments with NG-nitro-l-arginine methyl ester and tetraethylammonium in vitro suggested that both the nitric oxide- and hyperpolarization-mediated components of endothelium-dependent relaxation to acetylcholine were reduced in NaCl-hypertensive rats. All of the impaired relaxations in NaCl hypertension were normalized by concomitant Ca2+ supplementation. The 1OH-D3 treatment did not affect vascular relaxation, but it attenuated maximal contractile responses induced by norepinephrine and KCl by more than 50%. The reduced vasoconstrictor responses could not be explained by increased apoptosis in the vessel wall, but calcification may have played a role, since moderate signs of medial or adventitial calcification were observed in the aortic preparations after the 1OH-D3 treatment. In conclusion, a high-Ca2+ diet, which did not cause hypercalcemia, normalized blood pressure and endothelium-dependent and endothelium-independent vasorelaxation in NaCl-hypertensive rats. In contrast, chronic hypercalcemia induced by 1OH-D3 was associated with moderately lowered blood pressure, possibly because of reduced vasoconstrictor responses in arterial smooth muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960676     DOI: 10.1097/00005344-200309000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans.

Authors:  John P Forman; Jonathan S Williams; Naomi D L Fisher
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

Review 2.  Natural antioxidants and hypertension: promise and challenges.

Authors:  Tinoy J Kizhakekuttu; Michael E Widlansky
Journal:  Cardiovasc Ther       Date:  2010-03-29       Impact factor: 3.023

3.  Vitamin d and cardiovascular disease.

Authors:  Jacqueline S Danik; Joann E Manson
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-08

Review 4.  Vitamin D status and arterial hypertension: a systematic review.

Authors:  Stefan Pilz; Andreas Tomaschitz; Eberhard Ritz; Thomas R Pieber
Journal:  Nat Rev Cardiol       Date:  2009-08-18       Impact factor: 32.419

Review 5.  Protective cardiovascular and renal actions of vitamin D and estrogen.

Authors:  Pandu R Gangula; Yuan-Lin Dong; Ayman Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Georges Haddad; Rihcard Millis; Susanne B Nicholas; Diane Moseberry
Journal:  Front Biosci (Schol Ed)       Date:  2013-01-01

6.  Renin-angiotensin system activity in vitamin D deficient, obese individuals with hypertension: An urban Indian study.

Authors:  Sunil Kumar Kota; Siva Krishna Kota; Sruti Jammula; Lalit Kumar Meher; Sandip Panda; Prabhas Rranjan Tripathy; Kirtikumar D Modi
Journal:  Indian J Endocrinol Metab       Date:  2011-10

7.  Delayed progression to dialysis with early and intensive management of predialysis chronic kidney disease: a case-based approach.

Authors:  Stephen Thomsen
Journal:  Case Rep Nephrol Urol       Date:  2013-06-11

8.  Lipoic acid, but not tempol, preserves vascular compliance and decreases medial calcification in a model of elastocalcinosis.

Authors:  E Bassi; M Liberman; M K Martinatti; L A Bortolotto; F R M Laurindo
Journal:  Braz J Med Biol Res       Date:  2014-01-24       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.